NBE-Therapeutics announces today that Ulf Grawunder, who founded NBE-Therapeutics, will also serve as NBE-Therapeutic’s CEO. Ulf Grawunder has long standing experience in the field of therapeutic antibody discovery and development and will be able to leverage his technical expertise and his network in the (bio-)pharmaceutical industry for the development of antibody-based therapeutics, with a first focus on antibody drug conjugates.